Citigroup’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-68,683
Closed -$139K 7819
2016
Q1
$139K Buy
68,683
+42,276
+160% +$75.4K ﹤0.01% 5423
2015
Q4
$65K Buy
26,407
+24,327
+1,170% +$72.1K ﹤0.01% 5728
2015
Q3
$5K Sell
2,080
-1,027
-33% -$2.68K ﹤0.01% 6783
2015
Q2
$10K Sell
3,107
-3,911
-56% -$13.4K ﹤0.01% 6493
2015
Q1
$20K Sell
7,018
-9,199
-57% -$23.5K ﹤0.01% 6107
2014
Q4
$42K Buy
16,217
+11,754
+263% +$51.4K ﹤0.01% 5813
2014
Q3
$33K Buy
4,463
+2,704
+154% +$25.3K ﹤0.01% 5587
2014
Q2
$20K Sell
1,759
-10,156
-85% -$108K ﹤0.01% 5814
2014
Q1
$138K Sell
11,915
-11,707
-50% -$138K ﹤0.01% 4691
2013
Q4
$258K Buy
23,622
+22,182
+1,540% +$218K ﹤0.01% 4435
2013
Q3
$15K Sell
1,440
-1,981
-58% -$22.6K ﹤0.01% 6058
2013
Q2
$40K Buy
+3,421
New +$34.2K ﹤0.01% 5504

Citigroup's SZYM Position: Q2 2016 in Review

Citigroup sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 68,683 shares — an estimated $139K sold.

Citigroup first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $258K in Q4 2013. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Citigroup reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 68,683 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $139K.
  • Citigroup first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Citigroup's SOLAZYME INC COM STK (DE) position peaked at $258K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.